ArticleTheranostics2021

Erratum: Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum.

Jiang-Kai Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.